A Clinical Trial of Quadrivalent Influenza Virus Split Vaccine (MDCK Cells) for Individuals Aged 6 Months and Above.

NCT06342349 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Quadrivalent influenza virus split vaccine (MDCK cells)
BIOLOGICAL: Quadrivalent influenza virus split vaccine (Chicken embryo)
OTHER: Phosphate buffer solution

Sponsor

Shanghai Institute Of Biological Products

Collaborators

[object Object]